CDKN2B and neuroendocrine neoplasm: It has been shown that the expression of the p15INK4b gene product (p15) was significantly lower in lung neuroendocrine neoplasms, especially in neuroendocrine tumors, as well as in the adjacent normal lung, compared with non-neoplastic control lungs.